FABP4 and thalassemia: Based on this study, for further investigation, it is also possible for FABP4 to be a prognostic biomarker for cardiovascular complications in patients with thalassemia because the deterioration of cardiac function in patients with thalassemia may occur progressively due to cardiac iron accumulation.